8 clinical signs associated with impending death in patients with cancer identified
the ONA take:
According to a new study published in the journal Cancer, researchers at The University of Texas MD Anderson Cancer Center in Houston, Texas, have identified eight highly specific cognitive and physical signs associated with impending death in patients with cancer.
For the prospective study, researchers identified 357 patients with cancer admitted to palliative care units at MD Anderson Cancer Center and Barretos Cancer Hospital in Brazil. Of those patients, 57% died.
The team observed 52 cognitive and physical signs twice daily from the time of admission to discharge or death. Of those, researchers were able to identify eight signs that were most highly associated with impending death within 3 days of presentation.
Those signs include: decreased response to verbal stimuli, inability to close eyelids, nonreactive pupils, decreased response to visual stimuli, neck hyperextension, upper gastrointestinal bleeding, drooping of the nasolabial fold, and grunting of vocal cords.
The researchers note that although this information will not alter clinical practice, it may be helpful knowing that death is imminent so that caregivers can plan appropriately.
The authors also stress that these findings should only be applied to patients with cancer and not to other causes of death.
Researchers identified eight highly specific cognitive and physical signs associated with impending death in patients with cancer.
- FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy
- Efficacy of Octreotide LAR, Lanreotide in Management of Carcinoid Tumors
- Multivitamin Use May Reduce Risk of Chemo-Induced Neuropathy
- Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination
- Adjuvant Durvalumab Therapy May Prolong Progression-free Survival in NSCLC
- Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer
- Cannabis Reduces Response Rate to Immunotherapy for Cancer
- Perioperative Blockade of Pathways May Improve Outcomes in Breast Cancer
- Zika Virus Preferentially Targets Glioblastoma Stem Cells
- Daratumumab Infusion-Related Reactions Managed by Pre/Postinfusion Medications
- Lorazepam Plus Haloperidol Improves Agitation in Cancer-Related Delirium
- Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
- Treating Intractable Hiccups in Advanced Cancer, Palliative Care Setting
- Severe Mental Illness May Worsen Breast Cancer Survival Outcomes
- Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|